Capital Fund Management (CFM)’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Capital Fund Management (CFM)’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-402,791	Closed	-$7.23M	–	2335
2017 Q4	$7.23M	Buy	+402,791	New	+$4.96M	0.04%	516
2017 Q3	–	Sell	-12,800	Closed	-$134K	–	1863
2017 Q2	$134K	Sell	12,800 -25,181	-66%	-$257K	﹤0.01%	1406
2017 Q1	$418K	Buy	+37,981	New	+$441K	﹤0.01%	1196
2016 Q1	–	Sell	-49,600	Closed	-$858K	–	2016
2015 Q4	$858K	Buy	49,600 +32,658	+193%	+$586K	0.01%	929
2015 Q3	$337K	Buy	+16,942	New	+$388K	﹤0.01%	1186

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Capital Fund Management (CFM)'s SCMP Position: Q1 2018 in Review

Capital Fund Management (CFM) sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 402,791 shares — an estimated $7.23M sold.

Capital Fund Management (CFM) first reported a position in SCMP in Q3 2015 and held it in 5 quarters. The position peaked at $7.23M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Capital Fund Management (CFM) reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Capital Fund Management (CFM) sold 402,791 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $7.23M.
Capital Fund Management (CFM) first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2015 and held it in 5 quarters.
Capital Fund Management (CFM)'s Sucampo Pharmaceuticals, Inc. position peaked at $7.23M in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Capital Fund Management (CFM)'s 13F filing for Q1 2018, filed 15 May 2018.